Enasidenib in Combination With Cobimetinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT05441514 · COMPLETED
Trial details
- NCT number
- NCT05441514
- Sponsor
- City of Hope Medical Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-28
- Primary completion
- 2026-03-19
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.